Development pipeline

Balanced mix of new substance developments and life cycle management opportunities.

We focus on core competencies and its many years of experience. We thus hold a leading position in many therapeutic fields: for instance in the treatment of hemophilia and multiple sclerosis, in contrast media and oral contraception. We are also striving for such a leading position in oncology.

Our Company

02

Starting Phase

03

Medium Phase

04

Finishing Phase

05

After Drug Approval

06

Drugs Production

NeuroTau, Inc. is a biotech company, formed in 2017, that focuses on developing drugs that target the disruption or decay of the important neurobiological protein called Tau

Contact Us

Close Bitnami banner
Bitnami